Solara Active Pharma Sciences Limited (NSE:SOLARA)
530.50
+12.00 (2.31%)
Apr 24, 2025, 3:29 PM IST
NSE:SOLARA Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2017 - 2019 |
Revenue | 13,102 | 12,889 | 14,438 | 12,683 | 16,169 | 13,218 | Upgrade
|
Revenue Growth (YoY) | -6.88% | -10.73% | 13.84% | -21.56% | 22.33% | -4.68% | Upgrade
|
Cost of Revenue | 7,261 | 8,629 | 8,389 | 7,079 | 7,705 | 6,465 | Upgrade
|
Gross Profit | 5,840 | 4,261 | 6,049 | 5,605 | 8,464 | 6,752 | Upgrade
|
Selling, General & Admin | 2,215 | 2,500 | 2,308 | 2,392 | 2,327 | 2,080 | Upgrade
|
Other Operating Expenses | 1,909 | 2,703 | 2,353 | 2,349 | 2,205 | 1,999 | Upgrade
|
Operating Expenses | 5,126 | 6,236 | 5,773 | 5,864 | 5,618 | 5,021 | Upgrade
|
Operating Income | 714.4 | -1,975 | 275.9 | -259.9 | 2,846 | 1,732 | Upgrade
|
Interest Expense | -1,113 | -1,001 | -868 | -724.2 | -803.4 | -752.3 | Upgrade
|
Interest & Investment Income | 22.2 | 22.2 | 57.8 | 77.6 | 142.2 | 76.2 | Upgrade
|
Currency Exchange Gain (Loss) | 6.7 | 6.7 | 2.7 | 24.2 | -16.9 | -17.4 | Upgrade
|
Other Non Operating Income (Expenses) | -60.8 | -47.8 | -20.7 | -8.2 | -13.8 | 22.9 | Upgrade
|
EBT Excluding Unusual Items | -430.8 | -2,995 | -552.3 | -890.5 | 2,154 | 1,061 | Upgrade
|
Merger & Restructuring Charges | - | - | - | -34.9 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | 3.6 | 3.6 | -4.5 | -7.7 | 20 | -3.2 | Upgrade
|
Other Unusual Items | -1,897 | -1,897 | 100.2 | 17.5 | 38.2 | 18.3 | Upgrade
|
Pretax Income | -1,640 | -4,884 | -448.2 | -911 | 2,215 | 1,149 | Upgrade
|
Income Tax Expense | 887.9 | 785.4 | -225.7 | -328.1 | 1.5 | 3.9 | Upgrade
|
Earnings From Continuing Operations | -2,528 | -5,670 | -222.5 | -582.9 | 2,214 | 1,145 | Upgrade
|
Net Income to Company | -2,528 | -5,670 | -222.5 | -582.9 | 2,214 | 1,145 | Upgrade
|
Minority Interest in Earnings | 1.1 | -4.3 | 0.7 | 1.4 | 0.5 | 0.9 | Upgrade
|
Net Income | -2,527 | -5,674 | -221.8 | -581.5 | 2,214 | 1,146 | Upgrade
|
Net Income to Common | -2,527 | -5,674 | -221.8 | -581.5 | 2,214 | 1,146 | Upgrade
|
Net Income Growth | - | - | - | - | 93.18% | 92.59% | Upgrade
|
Shares Outstanding (Basic) | 26 | 36 | 36 | 36 | 32 | 26 | Upgrade
|
Shares Outstanding (Diluted) | 26 | 36 | 36 | 36 | 34 | 27 | Upgrade
|
Shares Change (YoY) | -28.14% | - | 0.15% | 4.75% | 28.19% | 8.24% | Upgrade
|
EPS (Basic) | -97.95 | -157.62 | -6.16 | -16.18 | 69.00 | 44.29 | Upgrade
|
EPS (Diluted) | -97.95 | -157.62 | -6.16 | -16.18 | 64.53 | 42.82 | Upgrade
|
EPS Growth | - | - | - | - | 50.70% | 97.11% | Upgrade
|
Free Cash Flow | - | 678.1 | 449.4 | -4,507 | -190.2 | -267.2 | Upgrade
|
Free Cash Flow Per Share | - | 18.84 | 12.48 | -125.38 | -5.54 | -9.98 | Upgrade
|
Dividend Per Share | - | - | - | - | 7.000 | 2.000 | Upgrade
|
Dividend Growth | - | - | - | - | 250.00% | -60.00% | Upgrade
|
Gross Margin | 44.58% | 33.06% | 41.90% | 44.19% | 52.35% | 51.09% | Upgrade
|
Operating Margin | 5.45% | -15.33% | 1.91% | -2.05% | 17.60% | 13.10% | Upgrade
|
Profit Margin | -19.29% | -44.02% | -1.54% | -4.58% | 13.69% | 8.67% | Upgrade
|
Free Cash Flow Margin | - | 5.26% | 3.11% | -35.53% | -1.18% | -2.02% | Upgrade
|
EBITDA | 1,678 | -979.8 | 1,315 | 793.3 | 3,872 | 2,614 | Upgrade
|
EBITDA Margin | 12.80% | -7.60% | 9.11% | 6.25% | 23.95% | 19.78% | Upgrade
|
D&A For EBITDA | 963.28 | 995.6 | 1,039 | 1,053 | 1,026 | 882.3 | Upgrade
|
EBIT | 714.4 | -1,975 | 275.9 | -259.9 | 2,846 | 1,732 | Upgrade
|
EBIT Margin | 5.45% | -15.33% | 1.91% | -2.05% | 17.60% | 13.10% | Upgrade
|
Effective Tax Rate | - | - | - | - | 0.07% | 0.34% | Upgrade
|
Revenue as Reported | 13,143 | 12,943 | 14,664 | 12,884 | 16,457 | 13,493 | Upgrade
|
Advertising Expenses | - | 33 | 8.6 | 3.8 | 3.1 | 15.6 | Upgrade
|
Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.